Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Rifaximin in Metabolic Dysfunction Associated Steatohepatitis: NCT07185932 Clinical Landscape Report 2026
18 September 2026
NCT07185932 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Betabart in Ovarian Cancer: NCT07189871 Clinical Landscape Report 2026
18 September 2026
NCT07189871 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MT-125 in Glioblastoma Multiforme: NCT07185880 Clinical Landscape Report 2026
18 September 2026
NCT07185880 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
TNBC(ProteinQure) in Locally Advanced Malignant Solid Neoplasm: NCT07190469 Clinical Landscape Report 2026
18 September 2026
NCT07190469 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
HRS-9813 in Idiopathic Pulmonary Fibrosis: NCT07192939 Clinical Landscape Report 2026
18 September 2026
NCT07192939 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Temozolomide in Glioblastoma Multiforme: NCT07195591 Clinical Landscape Report 2026
18 September 2026
NCT07195591 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nintedanib esylate in Idiopathic Pulmonary Fibrosis: NCT07194382 Clinical Landscape Report 2026
18 September 2026
NCT07194382 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Perflutren lipid microsphere in Neuroinflammation: NCT07193953 Clinical Landscape Report 2026
18 September 2026
NCT07193953 clinical landscape for Neuroinflammation: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Temozolomide in Metastatic Malignant Neoplasm to the Leptomeninges: NCT07193654 Clinical Landscape Report 2026
18 September 2026
NCT07193654 clinical landscape for Metastatic Malignant Neoplasm to the Leptomeninges: endpoints, sponsor, phase, geography, readouts, asset context and deve…
9 min read
EPC-003 in Recurrent Glioblastoma: NCT07193628 Clinical Landscape Report 2026
18 September 2026
NCT07193628 clinical landscape for Recurrent Glioblastoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Gallium Maltolate in Glioblastoma Multiforme: PACTR202509858954027 Clinical Landscape Report 2026
18 September 2026
PACTR202509858954027 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Nerandomilast in Idiopathic Pulmonary Fibrosis: NCT07201922 Clinical Landscape Report 2026
18 September 2026
NCT07201922 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.